ICON to open new hub in Ireland; Divis Laboratories to build third manufacturing facility in India;

> Icon, an Ireland-based clinical research company, said it will open a new global innovation hub in the country that will create 200 new jobs. Announcement

> Indian API maker Divis Laboratories reported to the Bombay Stock Exchange that it intends to build a third manufacturing facility in India. Story

> Walgreens Infusion Services in Houston is recalling three dozen infusion products for lack of sterility assurance. Report

> CDMO Vetter has completed a €26 million ($29.7 million) expansion of its site in Ravensburg, Germany, that includes new labs and an IT upgrade. Release

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

Pricing controversies shouldn't overshadow Phlow's promise to provide low-cost drugs to address COVID-19, says the CEO of partner Civica Rx.